581 related articles for article (PubMed ID: 16000575)
1. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
2. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
5. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
[TBL] [Abstract][Full Text] [Related]
6. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
[TBL] [Abstract][Full Text] [Related]
7. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer.
Yagi H; Miyamoto S; Tanaka Y; Sonoda K; Kobayashi H; Kishikawa T; Iwamoto R; Mekada E; Nakano H
Br J Cancer; 2005 May; 92(9):1737-45. PubMed ID: 15827558
[TBL] [Abstract][Full Text] [Related]
9. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway.
Panigone S; Hsieh M; Fu M; Persani L; Conti M
Mol Endocrinol; 2008 Apr; 22(4):924-36. PubMed ID: 18187604
[TBL] [Abstract][Full Text] [Related]
11. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of betacellulin and heparin-binding EGF-like growth factor in cultured zebrafish ovarian follicle cells by EGF family ligands.
Tse AC; Ge W
Comp Biochem Physiol A Mol Integr Physiol; 2009 May; 153(1):13-7. PubMed ID: 19000772
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
14. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
Thøgersen VB; Sørensen BS; Poulsen SS; Orntoft TF; Wolf H; Nexo E
Cancer Res; 2001 Aug; 61(16):6227-33. PubMed ID: 11507076
[TBL] [Abstract][Full Text] [Related]
15. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last.
Braun AH; Coffey RJ
Clin Cancer Res; 2005 Jul; 11(13):4639-43. PubMed ID: 16000554
[No Abstract] [Full Text] [Related]
18. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo.
Rittié L; Varani J; Kang S; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2006 Apr; 126(4):732-9. PubMed ID: 16470170
[TBL] [Abstract][Full Text] [Related]
19. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
